Search results

https://youtu.be/PTKznZXTjBU Les missions premières de l’ICSM répondant aux enjeux énergétiques consistent à : développer une recherche fondamentale en chimie et physico-chimie des procédés de la chimie séparative nécessaires à l’essor des énergies décarbonées, dans un contexte de raréfaction des ressources naturelles, en innovant pour séparer, trier et recycler (métaux stratégiques) ; concevoir et optimiser des matériaux pour anticiper les cycles du futur en développant une recherche pour un nucléaire durable et des énergies alternatives, avec l’ambition de recycler les matières valorisables. Label : Unité Mixte de Recherche (UMR)Tutelles principales : CNRS, CEA, UM, ENSCMPôle de recherche : ChimieÉcole doctorale : Sciences Chimiques BALARDPortail HAL : publications de la structure SITE WEB

https://youtu.be/VdXYTpmxIl4 Les recherches menées à l’ICGM s’intéressent à l’élaboration, la caractérisation et la mise en forme de matériaux fonctionnels à différentes échelles, de la molécule au dispositif en passant par les nanomatériaux. L’unité contribue au développement de solutions innovantes pour la résolution des enjeux sociétaux actuels que sont l’énergie, la santé et l’environnement, et développe de très nombreuses collaborations et projets qui sont pour la plupart de dimension internationale, avec des partenariats établis avec des laboratoires et universités du monde entier. L’ICGM est labélisé Institut Carnot Chimie Balard Cirimat et accompagne à ce titre, les industriels de plusieurs secteurs dans leurs projets R&D en science chimique et ingénierie, de la molécule au matériau. Label : Unité Mixte de Recherche (UMR)Tutelles principales : CNRS, UM, ENSCMPôle de recherche : ChimieÉcoles doctorales : Sciences Chimiques BALARD ; Information, Structures, Systèmes ; Sciences Chimiques et Biologiques pour la Santé ; Biodiversité, Agriculture, Alimentation, Environnement, Terre, EauPortail HAL : publications de la structure SITE WEB

IBMM develops research on biomolecules (lipids, sugars, proteins and DNA/RNA), which represent the basic building blocks of living organisms. This research, at the interface of chemistry and biology, contributes to a better understanding of physiological and pathophysiological mechanisms, as well as to the development of innovative tools for healthcare: new, more effective treatments (cancer, cardiovascular and neurodegenerative diseases), new medical devices, new cosmetological approaches and new diagnostic systems. The expertise of IBMM's teams covers : design by molecular modeling and synthesis of biomolecules and derivatives using more efficient, environmentally-friendly methods; development of analytical methods for biomolecule characterization and analysis in biological media; pharmacological, toxicological and in vitro biological studies of these biomolecules to validate their properties and select the most promising for development into new therapeutic and diagnostic systems and devices; IBMM's expertise makes it a unique laboratory for the valorization of its research, which has led to the marketing of two drugs (Macrilen, Sébivo) and the creation of several companies. Immersion at IBMM offers a unique training program for students wishing to take up the challenges of the future of living organisms. Label: Unité Mixte de Research (UMR)Main supervisory bodies: CNRS, UM, ENSCResearch field: ChemistryPhD schools: BALARD Chemical Sciences; Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

The Bacterial Virulence and Chronic Infections laboratory, VBIC (University of Montpellier, INSERM), was created on January 1, 2011, and is based at the UFR de Médecine Santé in Nîmes. Since January 2023, "L'équipe Projet Biologie des infections à Staphylocoques", located on the Triolet site in Montpellier, has joined VBIC. We have a "bench to bedside" approach, using basic and translational research to solve clinically relevant problems. Working closely with basic scientists, clinicians and biologists at the CHU de Nîmes, we use integrative, multidisciplinary approaches to understand the cellular and molecular basis of host/pathogen and microbial interactions in chronic wounds, and to apply our findings to clinical practice. We are also the National Reference Center for Brucellosis. We focus on the following pathologies: Brucellosis; Opportunistic infections caused by Burkholderia cepacia complex Chronic wound infections Staphylococcal infections. Label: Unité Mixte de Research (UMR)Tutelles principales: UM, InsermResearch cluster: Biology and HealthPhD school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

https://youtu.be/b6lRTV9H6AA?list=PL6WmOx60MnJe_iazdaxlxc1zC3Mx1K3Z0 Le laboratoire de Physiologie et Médecine Expérimentale du Cœur et des muscles, PhyMedExp, est une unité mixte de recherche (INSERM, CNRS, Université de Montpellier) créée le 1er janvier 2011. C’est une unité pluridisciplinaire fédérée autour de la physiologie et la physiopathologie des tissus contractiles (muscles cardiaque, lisse et strié), et leurs interactions avec leur environnement. Elle regroupe plus de 150 personnes sur 5 équipes et développe une stratégie de recherche allant de structures élémentaires (gènes et molécules), à l’organisme entier en passant par les cellules et les tissus. Les 5 équipes de la nouvelle unité PHYMEDEX sont : Équipe N°1 : Dynamique des couplages cardiaques. Équipe N°2 : Muscle et Déficiences d’Organes. Équipe N°3 : Maladies respiratoires et environnement. Équipe N°4 : Digestif : Développement et pathologies. Équipe N°5 : Maladies neuromusculaires et héréditaires. Label : Unité Mixte de Recherche (UMR)Tutelles principales : UM, Inserm, CNRSPôle de recherche : Biologie SantéÉcoles doctorales : Sciences du mouvement humain ; Sciences Chimiques et Biologiques pour la SantéPortail HAL : publications de la structure Site web

A multidisciplinary research unit made up of INSERM and EFS scientists, academics and university hospital staff. Competent in the field of infectiology research, UMR 1058 promotes translational research, between fundamental and clinical research, on the pathogenesis, transmission and control of HIV, other chronic infections (hepatitis viruses, mycobacteria) and emerging infections (arboviruses, prions), most often in partnership with research teams in the French West Indies and southern countries (sub-Saharan Africa and South-East Asia). UMR 1058 has received research funding from ANRS, ANR, the European Union (EDCTP and FP7), NIH/NIDA and various foundations. Label: Unité Mixte de Research (UMR)Tutelles principales: UM, Inserm, EFS, U ANTILLESResearch cluster: Biology and HealthPhD school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

The MMDN is an interdisciplinary laboratory dedicated to research into the biology of aging and neurodegenerative diseases. Using Drosophila, zebrafish, mouse and lemur animal models, and molecular biology, cell biology and pharmacology approaches, we target neurodegenerative diseases (Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis), rare diseases and spinal cord injury. Label : Unité Mixte de Research (UMR)Tutelles principales : UM, Inserm, EPHEPôle de recherche : Biologie SantéÉcole doctorale : Sciences Chimiques et Biologiques pour la SantéPortail HAL : publications de la structure SITE WEB

The research carried out by the LPHI teams aims to provide new insights into the study of biological membranes, in particular during parasitic (malaria, toxoplasmosis), bacterial (tuberculosis, salmonellosis, staphylococcal infections) and viral (antiviral defenses) infectious processes. The LPHI unit focuses on high-quality, innovative fundamental research in the field of biology. Research is based on integrated approaches involving genetics, molecular biology, biochemistry, structural biology and in vitro and in vivo cell biology. The laboratory collaborates with chemists and houses a team of theorists, physicists and mathematicians, to combine biology, chemistry, physics and mathematics in global or targeted multidisciplinary approaches to the biological processes studied. Label: Unité Mixte de Research (UMR)Main supervisory bodies: CNRS, INSERM, UMPôle de recherche: Biologie SantéDoctoral schools: Information, Structures, Systèmes; Sciences Chimiques et Biologiques pour la SantéHAL portal: publications of the structure WEBSITE

The aim of the Bioengineering and Nanoscience Laboratory's research is to contribute to the application of nanosciences to the fields of health and biology, with particular emphasis on dentistry. The main aim is to bring nanomaterials and nanosensors closer to clinical application, based on a high-quality methodological approach. Label : UR_UM104Main supervisor : UMPôle de recherche : Biologie SantéDoctoral school : Chemical and Biological Sciences for HealthHAL portal : publications of the structure WEBSITE

The IRMB brings together scientists and clinicians involved in regenerative medicine and immunotherapy, including both aspects of basic biology and innovative applications of regenerative therapy. The aim is to facilitate the transfer of stem cell biology research to clinical applications in coordination with clinicians specializing in chronic diseases (aging, rheumatoid arthritis, rare genetic diseases, diabetes, liver diseases, neurodegenerative diseases, musculoskeletal pathologies). Label: Unité Mixte de Research (UMR)Tutelles principales: UM, InsermResearch cluster: Biology and HealthPhD school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

Infectious diseases account for 35% of all deaths worldwide, and are the main cause of death in children and young adults. In addition, 17% of new cancer cases are thought to be caused by infectious agents. Infectiology research is therefore essential to better understand how an infectious agent multiplies within a living organism, so as to be able to prevent, treat and even cure the diseases induced by these infections. IRIM (Institut de Research en Infectiologie de Montpellier) is a research center focused on high-quality fundamental research in the fields of bacteriology, virology and immunity. Label: Unité Mixte de Research (UMR)Main supervisory bodies: CNRS, UMPolicy area: Biology and HealthPhD school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

The IRCM develops cognitive, multidisciplinary and applied research in the field of oncology. This research involves researchers and clinicians, and aims to understand the different stages of tumorigenesis, and ultimately to identify new diagnostic and therapeutic strategies against cancer. The Institute's unifying theme is "Molecular Targets and Cancer Therapy: Discovery, Biology and Clinical Applications". The teams' projects are organized around 2 main themes: Therapeutic antibodies in oncology: innovation, engineering, biological response; Plasticity of solid tumors and their microenvironment: phenotypic plasticity and signaling pathways, genetic and epigenetic alterations, treatment resistance. Label: Unité Mixte de Research (UMR)Tutelles principales: UM, Inserm, ICMPôle de recherche: Biologie SantéDoctoral schools: Information, Structures, Systèmes; Sciences Chimiques et Biologiques pour la SantéPortail HAL : publications de la structure WEBSITE

The Montpellier Neuroscience Institute is dedicated to studying the pathophysiology and therapies for sensory (hearing, vision, somesthesia) and motor deficits. In their research, the teams draw on multi-disciplinary strategies such as molecular genetics, cellular imaging, electrophysiology and the study of integrated systems to develop preclinical trials. INM teams work on a wide range of research topics: Genetics and therapy of retinal blindness; Physiology and pathophysiology of the inner ear; Development and pathophysiology of proprioceptive systems; Physiology and therapeutic approaches to spinal cord pathologies. Label: Unité Mixte de Research (UMR)Tutelles principales: UM, InsermResearch cluster: Biology and HealthPhD school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

Label : UR_UM103Main supervisors : UM, CHU de NîmesResearch pole : Health BiologyPhD schools : Chemical and Biological Sciences for Health ; Information, Structures, SystemsHAL portal : publications of the structure

The IGMM conducts excellent, innovative basic research with potential spin-offs for biomedical, molecular and cellular medicine, in particular for the treatment of cancer and certain infectious or genetic diseases.The IGMM has a long-standing, internationally recognized reputation in the disciplinary fields that make up its main areas of research: RNA Biology; Gene Regulation and Epigenetics; Tumorigenesis/Cell Cycle and Death; Immunology/Virology/Biotherapies. In addition to these main lines of research, the IGMM also has an interdisciplinary cross-disciplinary axis involving mathematical/computational modelling and machine learning to better understand the pathophysiological phenomena at the heart of its scientific interests. Translational research plays an increasingly important role in IGMM research, with a growing number of hospital partnerships in and outside Montpellier, and the inclusion of hospital practitioners in its teams. Label: Unité Mixte de Research (UMR)Main supervisory bodies: CNRS, UMPôle de recherche: Biologie SantéDoctoral school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE

The IGH carries out outstanding fundamental research, and aims to bring this research to fruition in the field of pathology. The main research themes are genome and chromatin dynamics, developmental genetics, epigenetic control and molecular and cellular pathologies. The IGH has established three major lines of research: Genome dynamics and epigenetic control. The main aspects of this research concern DNA replication, maintenance of genome integrity, recombination and meiosis, retrotransposition and its control, chromatin and nuclear organization, regulation of gene expression, and RNA silencing. Developmental genetics. This research relies heavily on model organisms such as Drosophila and transgenic mice. Topics covered include the cell cycle and microtubule dynamics, gonadal development, RNA regulation in development, neurogenetics and memory. Understanding, diagnosing and treating human pathologies. Our work focuses on DNA metabolism, epigenetic regulation and signaling pathways in cancer, the molecular basis of myogenesis, immunity, inflammatory diseases, AIDS, neurodegenerative diseases and cellular therapies. Label: Unité Mixte de Research (UMR)Main supervisors: CNRS, UMPôle de recherche: Biologie SantéDoctoral school: Chemical and Biological Sciences for HealthHAL portal: publications of the structure WEBSITE